Stimuli-responsive Drug Delivery Nanocarriers in the Treatment of Breast Cancer
- 2 June 2020
- journal article
- review article
- Published by Bentham Science Publishers Ltd. in Current Medicinal Chemistry
- Vol. 27 (15) , 2494-2513
Abstract
Stimuli-responsive drug-delivery nanocarriers (DDNs) have been increasingly reported in the literature as an alternative for breast cancer therapy. Stimuli-responsive DDNs are developed with materials that present a drastic change in response to intrinsic/chemical stimuli (pH, redox and enzyme) and extrinsic/physical stimuli (ultrasound, Near-infrared (NIR) light, magnetic field and electric current). In addition, they can be developed using different strategies, such as functionalization with signaling molecules, leading to several advantages, such as (a) improved pharmaceutical properties of liposoluble drugs, (b) selectivity with the tumor tissue decreasing systemic toxic effects, (c) controlled release upon different stimuli, which are all fundamental to improving the therapeutic effectiveness of breast cancer treatment. Therefore, this review summarizes the use of stimuli-responsive DDNs in the treatment of breast cancer. We have divided the discussions into intrinsic and extrinsic stimuli and have separately detailed them regarding their definitions and applications. Finally, we aim to address the ability of these stimuli-responsive DDNs to control the drug release in vitro and the influence on breast cancer therapy, evaluated in vivo in breast cancer models.Keywords
Funding Information
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - Brasil (Finance Code 001)
This publication has 123 references indexed in Scilit:
- Theranostic GO‐Based Nanohybrid for Tumor Induced Imaging and Potential Combinational Tumor TherapySmall, 2013
- The Role of Magnetic Nanoparticles in the Localization and Treatment of Breast CancerBioMed Research International, 2013
- Mitochondrial complex I activity and NAD+/NADH balance regulate breast cancer progressionJournal of Clinical Investigation, 2013
- Drug Release from Electric-Field-Responsive NanoparticlesACS Nano, 2011
- Thermoresponsive Polymer Colloids for Drug Delivery and Cancer TherapyMacromolecular Bioscience, 2011
- Hollow chitosan–silica nanospheres as pH-sensitive targeted delivery carriers in breast cancer therapyBiomaterials, 2011
- Tumor-homing photosensitizer-conjugated glycol chitosan nanoparticles for synchronous photodynamic imaging and therapy based on cellular on/off systemBiomaterials, 2011
- Cytoplasmic Delivery of Liposomes into MCF-7 Breast Cancer Cells Mediated by Cell-Specific Phage Fusion Coat ProteinMolecular Pharmaceutics, 2010
- Development of Biomedical Polymer-Silicate Nanocomposites: A Materials Science PerspectiveMaterials, 2010
- Mitochondrial dysfunction in human breast cancer cells and their transmitochondrial cybridsBiochimica et Biophysica Acta (BBA) - Bioenergetics, 2010